Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys

Passive immunotherapy against HIV-1 will most likely require broadly neutralizing antibodies (bnAbs) with maximum breadth and potency to ensure therapeutic efficacy. Recently, the novel CD4 binding site antibody N6 demonstrated extraordinary neutralization breadth and potency against large panels of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Virol
Prif Awduron: Julg, Boris, Pegu, Amarendra, Abbink, Peter, Liu, Jinyan, Brinkman, Amanda, Molloy, Katherine, Mojta, Shanell, Chandrashekar, Abishek, Callow, Katherine, Wang, Keyun, Chen, Xuejun, Schmidt, Stephen D., Huang, Jinghe, Koup, Richard A., Seaman, Michael S., Keele, Brandon F., Mascola, John R., Connors, Mark, Barouch, Dan H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2017
Pynciau:
Vaccines and Antiviral Agents
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5533891/
https://ncbi.nlm.nih.gov/pubmed/28539448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00498-17
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg